MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis
USA - NASDAQ:MDLZ - US6092071058 - Common Stock
61.54 USD
-0.59 (-0.95%)
Taking everything into account, MDLZ scores 5 out of 10 in our fundamental rating. MDLZ was compared to 87 industry peers in the Food Products industry. MDLZ scores excellent on profitability, but there are concerns on its financial health. MDLZ is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
MDLZ had positive earnings in the past year.
MDLZ had a positive operating cash flow in the past year.
MDLZ had positive earnings in each of the past 5 years.
In the past 5 years MDLZ always reported a positive cash flow from operatings.
1.2 Ratios
MDLZ's Return On Assets of 5.13% is fine compared to the rest of the industry. MDLZ outperforms 74.71% of its industry peers.
Looking at the Return On Equity, with a value of 13.90%, MDLZ belongs to the top of the industry, outperforming 81.61% of the companies in the same industry.
MDLZ has a better Return On Invested Capital (6.99%) than 72.41% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MDLZ is significantly below the industry average of 28.34%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 13.9% | ||
| ROIC | 6.99% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
MDLZ has a Profit Margin of 9.81%. This is amongst the best in the industry. MDLZ outperforms 85.06% of its industry peers.
MDLZ's Profit Margin has declined in the last couple of years.
MDLZ has a Operating Margin of 13.22%. This is in the better half of the industry: MDLZ outperforms 79.31% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ has a Gross Margin of 32.55%. This is in the better half of the industry: MDLZ outperforms 74.71% of its industry peers.
MDLZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.22% | ||
| PM (TTM) | 9.81% | ||
| GM | 32.55% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
MDLZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for MDLZ has been reduced compared to 1 year ago.
Compared to 5 years ago, MDLZ has less shares outstanding
The debt/assets ratio for MDLZ has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.42 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.42, MDLZ is in line with its industry, outperforming 57.47% of the companies in the same industry.
MDLZ has a debt to FCF ratio of 7.30. This is a slightly negative value and a sign of low solvency as MDLZ would need 7.30 years to pay back of all of its debts.
The Debt to FCF ratio of MDLZ (7.30) is better than 68.97% of its industry peers.
MDLZ has a Debt/Equity ratio of 0.76. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.76, MDLZ is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 7.3 | ||
| Altman-Z | 2.42 |
ROIC/WACC0.93
WACC7.48%
2.3 Liquidity
MDLZ has a Current Ratio of 0.64. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ has a Current ratio of 0.64. This is amonst the worse of the industry: MDLZ underperforms 88.51% of its industry peers.
A Quick Ratio of 0.39 indicates that MDLZ may have some problems paying its short term obligations.
MDLZ has a Quick ratio of 0.39. This is amonst the worse of the industry: MDLZ underperforms 80.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.64 | ||
| Quick Ratio | 0.39 |
3. Growth
3.1 Past
The earnings per share for MDLZ have decreased strongly by -10.37% in the last year.
Measured over the past 5 years, MDLZ shows a small growth in Earnings Per Share. The EPS has been growing by 6.91% on average per year.
Looking at the last year, MDLZ shows a small growth in Revenue. The Revenue has grown by 3.14% in the last year.
The Revenue has been growing slightly by 7.09% on average over the past years.
EPS 1Y (TTM)-10.37%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-15.12%
Revenue 1Y (TTM)3.14%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%7.68%
3.2 Future
Based on estimates for the next years, MDLZ will show a small growth in Earnings Per Share. The EPS will grow by 4.92% on average per year.
Based on estimates for the next years, MDLZ will show a small growth in Revenue. The Revenue will grow by 4.19% on average per year.
EPS Next Y-10.62%
EPS Next 2Y-0.91%
EPS Next 3Y2.64%
EPS Next 5Y4.92%
Revenue Next Year5.46%
Revenue Next 2Y5.02%
Revenue Next 3Y4.63%
Revenue Next 5Y4.19%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 19.79, which indicates a rather expensive current valuation of MDLZ.
MDLZ's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.49. MDLZ is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 18.17, the valuation of MDLZ can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDLZ indicates a somewhat cheap valuation: MDLZ is cheaper than 67.82% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, MDLZ is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.79 | ||
| Fwd PE | 18.17 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
MDLZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDLZ is cheaper than 62.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.83 | ||
| EV/EBITDA | 15.73 |
4.3 Compensation for Growth
The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.86
EPS Next 2Y-0.91%
EPS Next 3Y2.64%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.28%, MDLZ has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 5.05, MDLZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.43, MDLZ pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.28% |
5.2 History
On average, the dividend of MDLZ grows each year by 10.52%, which is quite nice.
MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
MDLZ pays out 66.77% of its income as dividend. This is not a sustainable payout ratio.
MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP66.77%
EPS Next 2Y-0.91%
EPS Next 3Y2.64%
NASDAQ:MDLZ (10/15/2025, 3:37:08 PM)
61.54
-0.59 (-0.95%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners88.19%
Inst Owner Change-0.05%
Ins Owners0.14%
Ins Owner Change0.32%
Market Cap79.63B
Analysts76.47
Price Target74.91 (21.73%)
Short Float %1.72%
Short Ratio2.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.28% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP66.77%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.87%
Min EPS beat(2)5.55%
Max EPS beat(2)10.18%
EPS beat(4)3
Avg EPS beat(4)6.73%
Min EPS beat(4)-3.07%
Max EPS beat(4)14.26%
EPS beat(8)7
Avg EPS beat(8)5.91%
EPS beat(12)11
Avg EPS beat(12)6.02%
EPS beat(16)13
Avg EPS beat(16)5.09%
Revenue beat(2)0
Avg Revenue beat(2)-1.25%
Min Revenue beat(2)-2.09%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.46%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.41%
Revenue beat(12)5
Avg Revenue beat(12)0.07%
Revenue beat(16)8
Avg Revenue beat(16)0.51%
PT rev (1m)-0.16%
PT rev (3m)2.21%
EPS NQ rev (1m)-1.07%
EPS NQ rev (3m)-10.2%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)0.13%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.79 | ||
| Fwd PE | 18.17 | ||
| P/S | 2.15 | ||
| P/FCF | 27.83 | ||
| P/OCF | 19.12 | ||
| P/B | 3.04 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.73 |
EPS(TTM)3.11
EY5.05%
EPS(NY)3.39
Fwd EY5.5%
FCF(TTM)2.21
FCFY3.59%
OCF(TTM)3.22
OCFY5.23%
SpS28.68
BVpS20.24
TBVpS-13.82
PEG (NY)N/A
PEG (5Y)2.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 13.9% | ||
| ROCE | 9.6% | ||
| ROIC | 6.99% | ||
| ROICexc | 7.19% | ||
| ROICexgc | 51.08% | ||
| OM | 13.22% | ||
| PM (TTM) | 9.81% | ||
| GM | 32.55% | ||
| FCFM | 7.71% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexcg growth 3Y30.99%
ROICexcg growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 7.3 | ||
| Debt/EBITDA | 3.17 | ||
| Cap/Depr | 98.04% | ||
| Cap/Sales | 3.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 66.77% | ||
| Profit Quality | 78.58% | ||
| Current Ratio | 0.64 | ||
| Quick Ratio | 0.39 | ||
| Altman-Z | 2.42 |
F-Score5
WACC7.48%
ROIC/WACC0.93
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.37%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-15.12%
EPS Next Y-10.62%
EPS Next 2Y-0.91%
EPS Next 3Y2.64%
EPS Next 5Y4.92%
Revenue 1Y (TTM)3.14%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%7.68%
Revenue Next Year5.46%
Revenue Next 2Y5.02%
Revenue Next 3Y4.63%
Revenue Next 5Y4.19%
EBIT growth 1Y-22.49%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year11.05%
EBIT Next 3Y8.25%
EBIT Next 5Y8.23%
FCF growth 1Y-1.28%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y6.39%
OCF growth 3Y5.84%
OCF growth 5Y4.37%